• 1. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 5. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Toluenes Tosyl compounds

Professional Introduction to 1-Chloro-4-(4-Methylbenzene)SulfonylBenzene (CAS No. 5184-71-4)

1-Chloro-4-(4-Methylbenzene)SulfonylBenzene, with the chemical formula C₁₄H₁₁ClO₂S, is a significant compound in the field of organic chemistry and pharmaceutical research. This compound, identified by its CAS number 5184-71-4, has garnered attention due to its versatile applications in synthesis and its potential role in developing novel therapeutic agents. The presence of both chloro and sulfonyl functional groups makes it a valuable intermediate in medicinal chemistry, enabling further derivatization into more complex molecules.

The structure of 1-Chloro-4-(4-Methylbenzene)SulfonylBenzene features a benzene ring substituted with a chloro group at the first position and a sulfonyl group linked to a 4-methylbenzene moiety at the fourth position. This arrangement imparts unique reactivity, making it a useful building block for constructing heterocyclic compounds and other pharmacophores. The sulfonyl group is particularly noteworthy, as it is frequently employed in drug design due to its ability to enhance binding affinity and metabolic stability.

In recent years, there has been growing interest in the synthetic utility of 1-Chloro-4-(4-Methylbenzene)SulfonylBenzene. Researchers have leveraged its reactivity to develop novel synthetic pathways for various biologically active compounds. For instance, the compound has been utilized in the preparation of sulfonamide derivatives, which are known for their antimicrobial and anti-inflammatory properties. The chloro substituent further enhances its synthetic value, allowing for nucleophilic aromatic substitution reactions that yield diverse scaffolds.

One of the most compelling aspects of 1-Chloro-4-(4-Methylbenzene)SulfonylBenzene is its potential application in neurological disorder research. Recent studies have suggested that sulfonyl-containing compounds may interact with specific neurotransmitter receptors, offering a promising avenue for developing treatments for conditions such as Alzheimer's disease and Parkinson's disease. The methyl group on the aromatic ring may also contribute to modulating the pharmacokinetic properties of derived compounds, influencing their bioavailability and efficacy.

The pharmaceutical industry has taken note of the versatility of 1-Chloro-4-(4-Methylbenzene)SulfonylBenzene. Several academic and industrial groups have reported novel derivatives synthesized from this compound that exhibit significant biological activity. For example, modifications involving the sulfonyl group have led to compounds with enhanced binding affinity to target proteins, while alterations around the aromatic core have improved solubility and cell permeability. These findings underscore the importance of this compound as a starting material for drug discovery programs.

From a chemical synthesis perspective, 1-Chloro-4-(4-Methylbenzene)SulfonylBenzene serves as an excellent precursor for introducing complex functional groups into organic molecules. Its stability under various reaction conditions allows for multiple synthetic transformations without degradation, making it a reliable choice for multi-step syntheses. Additionally, the compound's compatibility with both classical organic reactions and modern catalytic methods ensures broad applicability across different research domains.

The future prospects of 1-Chloro-4-(4-Methylbenzene)SulfonylBenzene in pharmaceutical development are vast. As research continues to uncover new biological targets and mechanisms, this compound is likely to play an increasingly important role in generating novel therapeutic agents. Its unique structural features provide a rich foundation for designing molecules with tailored properties, addressing unmet medical needs across various therapeutic areas.

In conclusion, 1-Chloro-4-(4-Methylbenzene)SulfonylBenzene (CAS No. 5184-71-4) is a multifaceted compound with significant potential in organic synthesis and pharmaceutical research. Its structural attributes, combined with its reactivity and synthetic utility, make it an invaluable asset for chemists and biologists alike. As advancements in drug discovery continue to evolve, this compound is poised to remain at the forefront of innovation in medicinal chemistry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)